Compare Enveric Biosciences Inc (ENVB) vs ON Holding AG (ONON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs ON Holding AG — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while ON Holding AG trades at $38.62 (market cap $12.49B). The key difference: ON Holding AG is far larger — about 2347.7× Enveric Biosciences Inc's market cap, and ON Holding AG is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | ONON | |
|---|---|---|
Market Cap | $5.32M | $12.49B |
Sector | Health | Technology |
52-Week High | $17.40 | $54.24 |
52-Week Low | $1.28 | $31.88 |
Enterprise Value | $408.82K | $11.81B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
ONON trades at $37.80, up 0.16% with neutral technical signals. The company shows strong fundamentals with Q1 2026 EPS beating expectations at $0.47 versus $0.34, revenue of $3.01B in 2025, and improving margins. Analyst sentiment is bullish with 77% buy ratings and a $47.33 consensus price target, suggesting 25% upside. Recent news highlights innovation and expansion into luxury lifestyle markets.
Outlook remains positive driven by earnings momentum and margin expansion, but risks include premium valuation and competitive pressures. The stock offers growth potential if execution continues, though high P/E of 40.42 requires sustained profit growth to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About ON Holding AG
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →
